RECRUITING

Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose is to find out if intraoperative acupuncture performed by needling PC 6 and LI4 point bilaterally, and Yin Tang point will help reduce the incidence postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy when added to a prophylactic regimen consisting of ondansetron and dexamethasone. The hypothesis is that the addition of this acupuncture treatment to ondansetron and dexamethasone given for prophylaxis will help reduce the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy when compared to patients receiving ondansetron and dexamethasone without acupuncture.

Official Title

Acupuncture For Prevention Of Postoperative Nausea And Vomiting In Patients Undergoing Laparoscopic Cholecystectomy - A Randomized Controlled Trial

Quick Facts

Study Start:2023-10-09
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05975385

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 64 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Patient ages 18-64
  2. 2. American Society of Anesthesiology Physical Status I, II or III
  3. 3. Patients scheduled to undergo laparoscopic cholecystectomy at Harris Health System Ben Taub Hospital
  1. 1. Scheduled open cholecystectomy - excluded due to increased levels of pain in open procedures
  2. 2. Renal dysfunction (Serum Cr \> 1.2) - excluded due to potential altered metabolism of anesthetic and perioperative medications
  3. 3. Allergy to any of the standard anesthetic agents
  4. 4. Patient inability to properly communicate with investigators (language barrier, dementia, delirium, psychiatric disorder)
  5. 5. Patient or surgeon refusal

Contacts and Locations

Study Contact

Jaime Ortiz, MD, MBA
CONTACT
713-873-2860
jaimeo@bcm.edu

Study Locations (Sites)

Ben Taub Hospital
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: Baylor College of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-09
Study Completion Date2025-12

Study Record Updates

Study Start Date2023-10-09
Study Completion Date2025-12

Terms related to this study

Additional Relevant MeSH Terms

  • Cholecystitis, Acute
  • Cholelithiasis
  • Nausea, Postoperative
  • Vomiting, Postoperative
  • Pain, Postoperative